The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dometuss-Dm
GUAIFENESIN, DEXTROMETHORPHAN HBr · GUAIFENESIN 30 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/5mL · Liquid · Oral · Domel Laboratories
NDC 53809-0201-01 · 30 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for dextromethorphan hbr, guaifenesin (other) in the next 90 days
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of GUAIFENESIN, DEXTROMETHORPHAN HBr (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | GUAIFENESIN 200 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/5mL | Aug 26, 2026 | Sep 3, 2026 |
| Menper Distributors, Inc. | GUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL | Aug 26, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | GUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | GUAIFENESIN 30 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/5mL | Jul 22, 2026 | Aug 21, 2026 |
| Menper Distributors, Inc. | GUAIFENESIN 20 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/10mL | Jul 22, 2026 | Aug 19, 2026 |
| Rising Pharma Holdings, Inc. | GUAIFENESIN 10 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 100 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Domel Laboratories | GUAIFENESIN 30 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/5mL | Jul 22, 2026 | Jul 29, 2026 |
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/5mL; GUAIFENESIN 200 mg/5mL | Jul 15, 2026 | Jul 19, 2026 |
| Domel Laboratories | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/5mL; GUAIFENESIN 200 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
| Menper Distributors, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL | Jul 15, 2026 | Jul 15, 2026 |
| Rising Pharma Holdings, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL; GUAIFENESIN 100 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dometuss-Dm — NDC 53809-0201-01," retrieved September 3, 2026, https://drugdashboards.com/drug/53809020101.
Free to cite with attribution — see how the data is put together.